In this nonischemic cardiomyopathy, there was no observed decrease in the levels of Cx43 at baseline, and likewise no observed difference in Cx43 between the targeted and nontargeted segments (Fig. 8c). Here, GJA1 is linked to nonischemic cardiomyopathy.